Lee E - Search Results

1

Synthesis and anti-melanogenic activity of hydroxyphenyl benzyl ether analogues.

Sapkota K, Roh E, Lee E, Ha EM, Yang JH, Lee ES, Kwon Y, Kim Y, Na Y. Sapkota K, et al. Among authors: lee e, lee es. Bioorg Med Chem. 2011 Apr 1;19(7):2168-75. doi: 10.1016/j.bmc.2011.02.044. Epub 2011 Feb 26. Bioorg Med Chem. 2011. PMID: 21429753

2

Molecular modeling of 3-arylisoquinoline antitumor agents active against A-549. A comparative molecular field analysis study.

Cho WJ, Kim EK, Park IY, Jeong EY, Kim TS, Le TN, Kim DD, Lee ES. Cho WJ, et al. Bioorg Med Chem. 2002 Sep;10(9):2953-61. doi: 10.1016/s0968-0896(02)00137-2. Bioorg Med Chem. 2002. PMID: 12110317

3

Simple aromatic compounds containing propenone moiety show considerable dual COX/5-LOX inhibitory activities.

Jahng Y, Zhao LX, Moon YS, Basnet A, Kim EK, Chang HW, Ju HK, Jeong TC, Lee ES. Jahng Y, et al. Bioorg Med Chem Lett. 2004 May 17;14(10):2559-62. doi: 10.1016/j.bmcl.2004.02.099. Bioorg Med Chem Lett. 2004. PMID: 15109651

4

2,4,6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.

Basnet A, Thapa P, Karki R, Na Y, Jahng Y, Jeong BS, Jeong TC, Lee CS, Lee ES. Basnet A, et al. Bioorg Med Chem. 2007 Jul 1;15(13):4351-9. doi: 10.1016/j.bmc.2007.04.047. Epub 2007 Apr 29. Bioorg Med Chem. 2007. PMID: 17493824

5

Design, docking, and synthesis of novel indeno[1,2-c]isoquinolines for the development of antitumor agents as topoisomerase I inhibitors.

Cho WJ, Le QM, My Van HT, Youl Lee K, Kang BY, Lee ES, Lee SK, Kwon Y. Cho WJ, et al. Bioorg Med Chem Lett. 2007 Jul 1;17(13):3531-4. doi: 10.1016/j.bmcl.2007.04.064. Epub 2007 Apr 25. Bioorg Med Chem Lett. 2007. PMID: 17498951

6

Synthesis of 2,6-diaryl-substituted pyridines and their antitumor activities.

Son JK, Zhao LX, Basnet A, Thapa P, Karki R, Na Y, Jahng Y, Jeong TC, Jeong BS, Lee CS, Lee ES. Son JK, et al. Eur J Med Chem. 2008 Apr;43(4):675-82. doi: 10.1016/j.ejmech.2007.05.002. Epub 2007 May 27. Eur J Med Chem. 2008. PMID: 17673337

7

Convenient synthesis of indeno[1,2-c]isoquinolines as constrained forms of 3-arylisoquinolines and docking study of a topoisomerase I inhibitor into DNA-topoisomerase I complex.

Van HT, Le QM, Lee KY, Lee ES, Kwon Y, Kim TS, Le TN, Lee SH, Cho WJ. Van HT, et al. Bioorg Med Chem Lett. 2007 Nov 1;17(21):5763-7. doi: 10.1016/j.bmcl.2007.08.062. Epub 2007 Aug 29. Bioorg Med Chem Lett. 2007. PMID: 17827007

8

New insight for fluoroquinophenoxazine derivatives as possibly new potent topoisomerase I inhibitor.

Kang DH, Kim JS, Jung MJ, Lee ES, Jahng Y, Kwon Y, Na Y. Kang DH, et al. Bioorg Med Chem Lett. 2008 Feb 15;18(4):1520-4. doi: 10.1016/j.bmcl.2007.12.053. Epub 2007 Dec 25. Bioorg Med Chem Lett. 2008. PMID: 18178085

9

2-Thienyl-4-furyl-6-aryl pyridine derivatives: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.

Thapa P, Karki R, Thapa U, Jahng Y, Jung MJ, Nam JM, Na Y, Kwon Y, Lee ES. Thapa P, et al. Bioorg Med Chem. 2010 Jan 1;18(1):377-86. doi: 10.1016/j.bmc.2009.10.049. Epub 2009 Oct 29. Bioorg Med Chem. 2010. PMID: 19939682

10

2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-activity relationship, and docking study.

Basnet A, Thapa P, Karki R, Choi H, Choi JH, Yun M, Jeong BS, Jahng Y, Na Y, Cho WJ, Kwon Y, Lee CS, Lee ES. Basnet A, et al. Bioorg Med Chem Lett. 2010 Jan 1;20(1):42-7. doi: 10.1016/j.bmcl.2009.11.041. Epub 2009 Nov 14. Bioorg Med Chem Lett. 2010. PMID: 19954977

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23,756 results

Search Page

Filters